Decrease of Hsp25 protein expression precedes degeneration of motoneurons in ALS-SOD1 mice

The European Journal of Neuroscience
Arjen MaatkampDick Jaarsma

Abstract

We have investigated the expression of Hsp25, a heat shock protein constitutively expressed in motoneurons, in amyotrophic lateral sclerosis (ALS) mice that express G93A mutant SOD1 (G93A mice). Immunocytochemistry and Western blotting showed that a decrease of Hsp25 protein expression occurred in motoneurons of G93A mice prior to the onset of motoneuron death and muscle weakness. This decrease in Hsp25 expression also preceded the appearance of SOD1 aggregates as identified by cellulose acetate filtration and Western blot analysis. In contrast to Hsp25 protein levels, Hsp25 mRNA as determined by in situ hybridization and RT-PCR, remained unchanged. This suggests that the decrease in Hsp25 protein levels occurs post-transcriptionally. In view of the cytoprotective properties of Hsp25 and the temporal relationship between decreased Hsp25 expression and the onset of motoneuron death, it is feasible that reduced Hsp25 concentration contributes to the degeneration of motoneurons in G93A mice. These data are consistent with the idea that mutant SOD1 may reduce the availability of the protein quality control machinery in motoneurons.

References

Jul 1, 1993·Neuroreport·U ArvidssonT Hökfelt
May 1, 1997·Journal of Neuropathology and Experimental Neurology·H D DurhamD A Figlewicz
Dec 5, 1998·Brain Research. Molecular Brain Research·A K MurashovD J Wolgemuth
May 18, 1999·The Journal of Biological Chemistry·M EhrnspergerJ Buchner
Sep 12, 2000·Nature Cell Biology·J M BrueyC Garrido
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·J A JohnstonR R Kopito
Oct 9, 2001·Brain Research. Molecular Brain Research·A K MurashovD J Wolgemuth
Apr 2, 2002·The Journal of Biological Chemistry·Philip EatonMichael J Shattock
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ayako Okado-Matsumoto, Irwin Fridovich
Sep 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kanefusa KatoYutaka Inaguma
Nov 15, 2002·Journal of Neuropathology and Experimental Neurology·Vicky VleminckxWim Robberecht
Nov 30, 2002·The Journal of Biological Chemistry·Ashutosh Tiwari, Lawrence J Hayward
Dec 20, 2002·Angewandte Chemie·Stefan Walter, Johannes Buchner
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Joan Selverstone Valentine, P John Hart
May 16, 2003·The Journal of Biological Chemistry·Lori Sturtz FieldValeria Cizewski Culotta
May 20, 2003·Nature Structural Biology·Jennifer Stine ElamP John Hart
May 22, 2003·Free Radical Biology & Medicine·Stefan I Liochev, Irwin Fridovich
Oct 10, 2003·Brain : a Journal of Neurology·P Andreas JonssonStefan L Marklund

❮ Previous
Next ❯

Citations

Sep 21, 2012·Cell Stress & Chaperones·Justin J YerburyHeath Ecroyd
Nov 26, 2010·The Cerebellum·Carol L ArmstrongMichael William Vogel
Oct 7, 2005·The New England Journal of Medicine·Alberto J L Macario, Everly Conway de Macario
Feb 28, 2009·Human Molecular Genetics·Natalia NinkinaVladimir L Buchman
Mar 27, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Serena CarraAngelo Poletti
May 5, 2011·Disease Models & Mechanisms·Abraham Acevedo-ArozenaElizabeth M C Fisher
Dec 22, 2009·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Hiroaki AdachiGen Sobue
Nov 27, 2009·Expert Opinion on Investigational Drugs·Veena LankaMerit Cudkowicz
Jan 1, 2016·Neuroscience·Shmma QuraisheVincent O'Connor
Apr 24, 2012·Neurobiology of Disease·Amit K SrivastavaStephen J Kolb
Feb 11, 2010·Neuroscience Letters·Anisha A GupteJohn A Stanford
Mar 3, 2009·Biochemical and Biophysical Research Communications·Danielle E Read, Adrienne M Gorman
Feb 8, 2008·Neurobiology of Disease·Paul S SharpJacqueline de Belleroche
Aug 13, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pavel StrnadM Bishr Omary
Apr 16, 2010·The Journal of Comparative Neurology·C A DuffinC L Armstrong
Jun 30, 2006·Experimental Neurology·J KrishnanL Van Den Bosch
Mar 7, 2006·Current Opinion in Chemical Biology·P John Hart
Feb 25, 2006·Experimental Neurology·Paul SharpJacqueline de Belleroche
Sep 23, 2008·Biochimica Et Biophysica Acta·P StrnadH Denk
Aug 15, 2008·Neurobiology of Aging·Georgia AnagnostouJacqueline de Belleroche
Aug 1, 2006·Biochimica Et Biophysica Acta·Edor Kabashi, Heather D Durham
Nov 19, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Priyanka PatelJasna Kriz
Nov 25, 2014·Nature Neuroscience·Brian J WaingerClifford J Woolf
Sep 11, 2009·Journal of Inorganic Biochemistry·Christopher A Shaw, Michael S Petrik
Oct 4, 2017·Brain : a Journal of Neurology·Elias AdriaenssensVincent Timmerman
Jun 2, 2006·The Journal of Comparative Neurology·Martijn SchonewilleChris I De Zeeuw
Oct 6, 2005·Annals of Medicine·Ines DierickVincent Timmerman

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.